Generics 1

Biosimilars

Medical devices

Nutraceuticals

Filters

Ioversol manufacturers

1 products found

Filters

1 products found

ioversol

Vials, injection 678 mg

Dossier type
CTD
Country of origin
South Korea
Dossier status
Ready
GMP approvals
PICS

Manufacturer #17938

The company is focused to produce the best products with the experience and practical know-how and willingness to become a company that always keeps on trying to do its best. They produce excellent medicine suitable for GMP requirements through strict quality management in each step from the warehousing of raw materials to the manufacturing process, packing, and shipment. Productivity maximization, as well as quality assurance, is enhanced with recently introduced various manufacturing facilities.

Manufacturer usually replies in 2 days

IOVERSOL Manufacturers

Ioversol is a RAY dee oh payk (radiopaque) contrast agent. This pharmaceutical remedy contains iodine, a substance that absorbs x-rays. Contrast agents are used for allowing organs, blood vessels, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (x-ray) examination. This medical drug is used for helping diagnose certain disorders of the brain, heart, and blood vessels. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking this medicine: You should not use IOVERSOLif you are allergic to it IOVERSOL may also is used for purposes that may not have been listed in this medication guide.

How to use IOVERSOL?

Read the IOVERSOL Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking IOVERSOL. If you have any questions related to IOVERSOL, ask your pharmacist or doctor.

How much money does IOVERSOL cost?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost for IOVERSOL 240 injectable solution 51% is around $380 for a supply of 1200 milliliters. Prices may vary on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of IOVERSOL offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for IOVERSOL manufacturers and IOVERSOL suppliers that you are looking for. These also enable you to check the dossier status of IOVERSOL, and the GMP approvals of the different variants of IOVERSOL. Also, each manufacturer or supplier product description contains essential information about IOVERSOL including clinical data, stability zones, countries where IOVERSOL is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.